284 related articles for article (PubMed ID: 25675517)
1. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis.
Peres RS; Liew FY; Talbot J; Carregaro V; Oliveira RD; Almeida SL; França RF; Donate PB; Pinto LG; Ferreira FI; Costa DL; Demarque DP; Gouvea DR; Lopes NP; Queiroz RH; Silva JS; Figueiredo F; Alves-Filho JC; Cunha TM; Ferreira SH; Louzada-Junior P; Cunha FQ
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2509-14. PubMed ID: 25675517
[TBL] [Abstract][Full Text] [Related]
2. TGF-β signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis.
Peres RS; Donate PB; Talbot J; Cecilio NT; Lobo PR; Machado CC; Lima KWA; Oliveira RD; Carregaro V; Nakaya HI; Cunha TM; Alves-Filho JC; Liew FY; Louzada-Junior P; Cunha FQ
J Autoimmun; 2018 Jun; 90():49-58. PubMed ID: 29426578
[TBL] [Abstract][Full Text] [Related]
3. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
[TBL] [Abstract][Full Text] [Related]
4. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma.
Wang LL; Tang HP; Shi GC; Wan HY; Tang W; Hou XX; Pan LN; Shi BY; Tao LQ
Mol Med Rep; 2013 Nov; 8(5):1432-8. PubMed ID: 24065069
[TBL] [Abstract][Full Text] [Related]
5. Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4
Han L; Sugiyama H; Zhang Q; Yan K; Fang X; McCormick TS; Cooper KD; Huang Q
Australas J Dermatol; 2018 Feb; 59(1):e31-e38. PubMed ID: 28295154
[TBL] [Abstract][Full Text] [Related]
6. B cells from Patients with Rheumatoid Arthritis Show Conserved CD39-Mediated Regulatory Function and increased CD39 Expression After Positive Response to Therapy.
Zacca ER; Amezcua Vesely MC; Ferrero PV; Acosta CDV; Ponce NE; Bossio SN; Mussano E; Onetti L; Cadile I; Acosta Rodríguez EV; Montes CL; Gruppi A
J Mol Biol; 2021 Jan; 433(1):166687. PubMed ID: 33098857
[TBL] [Abstract][Full Text] [Related]
7. CD39 expression on immune cells predicts methotrexate response in rheumatoid arthritis patients.
Boral B; Tuncer İ; Kibar F; Çetiner S; Badak SÖ; Salman E; Koç E; Erken E; Yaman A
Turk J Med Sci; 2023; 53(5):1075-1083. PubMed ID: 38813034
[TBL] [Abstract][Full Text] [Related]
8. [Increased percentage and defective inhibitory function of CD4
Zhang R; Miao J; Zhang K; Zheng Z; Zhu P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):961-966. PubMed ID: 31878990
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
[TBL] [Abstract][Full Text] [Related]
10. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.
Schuler PJ; Saze Z; Hong CS; Muller L; Gillespie DG; Cheng D; Harasymczuk M; Mandapathil M; Lang S; Jackson EK; Whiteside TL
Clin Exp Immunol; 2014 Aug; 177(2):531-43. PubMed ID: 24749746
[TBL] [Abstract][Full Text] [Related]
11. CD39+ regulatory T cells attenuate allergic airway inflammation.
Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
[TBL] [Abstract][Full Text] [Related]
12. Adenosine Generated by Regulatory T Cells Induces CD8
Shi L; Feng M; Du S; Wei X; Song H; Yixin X; Song J; Wenxian G
Biomed Res Int; 2019; 2019():4093214. PubMed ID: 31930120
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate and BAFF interaction prevents immunization against TNF inhibitors.
Bitoun S; Nocturne G; Ly B; Krzysiek R; Roques P; Pruvost A; Paoletti A; Pascaud J; Dönnes P; Florence K; Gleizes A; Hincelin-Mery A; Allez M; Hacein-Bey-Abina S; Mackay F; Pallardy M; Le Grand R; Mariette X
Ann Rheum Dis; 2018 Oct; 77(10):1463-1470. PubMed ID: 29936438
[TBL] [Abstract][Full Text] [Related]
14. Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response.
Ortiz MA; Diaz-Torné C; De Agustin JJ; Estrada P; Reina D; Hernandez MV; Sang H; Zamora C; Cantó E; Corominas H; Vidal S
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38275742
[TBL] [Abstract][Full Text] [Related]
15. Human CD39
Gu J; Ni X; Pan X; Lu H; Lu Y; Zhao J; Guo Zheng S; Hippen KL; Wang X; Lu L
Cell Mol Immunol; 2017 Jun; 14(6):521-528. PubMed ID: 27374793
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
Xinqiang S; Fei L; Nan L; Yuan L; Fang Y; Hong X; Lixin T; Juan L; Xiao Z; Yuying S; Yongzhi X
Biomed Pharmacother; 2010 Sep; 64(7):463-71. PubMed ID: 20359858
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation.
Chen M; Su W; Lin X; Guo Z; Wang J; Zhang Q; Brand D; Ryffel B; Huang J; Liu Z; He X; Le AD; Zheng SG
Arthritis Rheum; 2013 May; 65(5):1181-93. PubMed ID: 23400582
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis.
Lina C; Conghua W; Nan L; Ping Z
J Clin Immunol; 2011 Aug; 31(4):596-605. PubMed ID: 21562776
[TBL] [Abstract][Full Text] [Related]
19. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.
Deaglio S; Dwyer KM; Gao W; Friedman D; Usheva A; Erat A; Chen JF; Enjyoji K; Linden J; Oukka M; Kuchroo VK; Strom TB; Robson SC
J Exp Med; 2007 Jun; 204(6):1257-65. PubMed ID: 17502665
[TBL] [Abstract][Full Text] [Related]
20. Target tissue ectoenzyme CD39/CD73-expressing Foxp3+ regulatory T cells in patients with psoriasis.
Zhang HY; Yan KX; Huang Q; Ma Y; Fang X; Han L
Clin Exp Dermatol; 2015 Mar; 40(2):182-91. PubMed ID: 25284153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
